SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Hellenic Dynamics to be first cannabis cultivator on LSE

    By
    Home / Hellenic Dynamics to be first cannabis cultivator on LSE

    AIM-listed cash shell company UK SPAC Plc has confirmed that the Financial Conduct Authority (FCA) has approved the prospectus of UK SPAC in connection with the proposed acquisition of Hellenic Dynamics.

    The approval covers the re-admission of the enlarged share capital to the standard listing segment of the Official List and to trading on the London Stock Exchange’s Main Market. 

    The development will make Hellenic Dynamics the first medical cannabis cultivator listed on the Main Market. Although there are a few companies listed on the London Stock Exchange’s Main Market that fall within the “cannabis” sector, no medical cannabis cultivator is listed.

    Read more: CROP17 ramps up UK cannabis venture offering

    Completion of the proposed acquisition of Hellenic Dynamics will take place on 5 December 2022. The admission and commencement of dealings on the London Stock Exchange of the enlarged issued share capital is expected to occur on the same day.

    Chief Executive Officer of Hellenic Dynamics, Davinder Rai, said: “Chronic pain is one of the most expensive issues for the NHS and 26% of the UK population is suffering from it. As a result, over 1 million people in the UK use illegal cannabis with medical intent. 

    “It is our aim to be the supplier of choice to the NHS of high quality, competitively priced and fully regulated THC-dominant medical cannabis. 

    “Hellenic’s admission to the Main Market as the first medical cannabis cultivator marks a major step forward not just for the company but also for the millions of people around the world who will benefit from our life-enhancing medical products.”

    Hellenic Dynamics is a private Greek company specifically involved in the cultivation and production of THC-dominant strains of medical cannabis flowers and end-user medical cannabis products, destined for the growing medical cannabis markets across Europe.

    Sales of Hellenic Dynamics’ THC-dominant medical cannabis products are intended for export into the emerging medical cannabis markets in Europe along with supply to the Greek domestic market.

    Hellenic Dynamics has signed two term sheets for off-take which it anticipates will be the first two years of production with medical cannabis distributors in Germany. In addition, the company has entered into an MOU with Kanabo Group Plc, pursuant to which Kanabo may purchase certain quantities of medical cannabis products for distribution in the United Kingdom and Germany.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free